论文部分内容阅读
近年来,随着“清除自由基理论”的深入探讨研究,自由基清除剂在脑血管疾病治疗中的应用备受广大医学工作者的关注。为了进一步研讨自由基清除剂——易达生(依达拉奉注射液)在脑血管疾病治疗中的应用进展,促进临床经验交流。中国卒中杂志社与吉林博大制药有限责任公司共同举办“易达生(依达拉奉注射液)”有奖征文活动。1 征文内容:神经内科疾病、颅脑损伤及脑动脉瘤等神经外科疾病与清除自由基脑保护治疗。2 征文要求:主题新颖,内容具有创新性,如:给药时间的创新、给药剂量的创新、安全性研究等;未在其他杂志发表过。具体要求如下:
In recent years, with the “radical scavenging theory ” in-depth study, free radical scavenger in the treatment of cerebrovascular disease has attracted the attention of the majority of medical workers. In order to further explore the free radical scavenger - easy to reach (Edaravone injection) in the treatment of cerebrovascular disease progress, and promote clinical experience exchange. China Stroke Magazine and Jilin Boda Pharmaceutical Co., Ltd. jointly organized the “Easy to reach (Edaravone Injection) ” prize essay activities. 1 Essay content: neurological diseases, brain injury and brain aneurysm and other neurosurgical diseases and brain protection of free radical scavenging treatment. 2 Essay Requirements: The theme is novel, the content is innovative, such as: the timing of drug delivery, drug dose innovation, safety studies; not published in other magazines. Specific requirements are as follows: